Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Dow
AstraZeneca
Medtronic
Colorcon

Last Updated: January 28, 2022

DrugPatentWatch Database Preview

Litigation Details for ELI LILLY AND COMPANY v. APOTEX INC. (S.D. Ind. 2016)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in ELI LILLY AND COMPANY v. APOTEX INC.
The small molecule drug covered by the patents cited in this case is ⤷  Sign up for a Free Trial .

Details for ELI LILLY AND COMPANY v. APOTEX INC. (S.D. Ind. 2016)

Date Filed Document No. Description Snippet Link To Document
2017-02-07 81 spreading implement patents at issue in this case (the ’861 Patent and U.S. Patent Nos. 8,419,307; 8,177,449;…asserting various claims of patent infringement as to seven of the patents related to Axiron (hereinafter…hereinafter referred to collectively as “the Patents”). The Patents are owned by Plaintiff Acrux DDS PTY Ltd…those ANDAs infringed upon nine patents, including five of the seven patents at issue in this case.1 After…inter alia, one claim in one of the Patents in this case (“the ’944 Patent”) 2 invalid and finding two claims External link to document
2017-05-03 86 spreading implement patents at issue in this case (the ’861 Patent and U.S. Patent Nos. 8,419,307; 8,177,449;…than just the applicator patents. The claims with regard to the applicator patents do, indeed, appear to…sue the Defendants with regard to four of the patents on which the Plaintiffs sued in this case (hereinafter…hereinafter referred to as the “applicator patents”). The Defendants fault the Plaintiffs for failing to…failure to inform the Court that the applicator patents are no longer at issue.” Dkt. No. 83 at 2. 1 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Express Scripts
Johnson and Johnson
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.